Literature DB >> 2841868

Molecular events in expression of vasopressin and oxytocin and their cognate receptors.

D Richter1.   

Abstract

This article focuses on some aspects of neuropeptide gene expression using as examples the hypothalamic hormones vasopressin and oxytocin. Their transcriptional and translational expressions as polyproteins have been outlined, including the analysis of the genetic defect in the expression of vasopressin by the Brattleboro gene. The interaction of neuropeptide hormones with their target organs is discussed. A molecular approach toward the identification of the respective neuropeptide hormone receptors is described.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841868     DOI: 10.1152/ajprenal.1988.255.2.F207

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Regulation of c-fos and c-jun expression in the rat supraoptic nucleus.

Authors:  D A Carter; D Murphy
Journal:  Cell Mol Neurobiol       Date:  1990-09       Impact factor: 5.046

2.  Cell-type specific oxytocin gene expression from AAV delivered promoter deletion constructs into the rat supraoptic nucleus in vivo.

Authors:  Raymond L Fields; Todd A Ponzio; Makoto Kawasaki; Harold Gainer
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 3.  Cell-type specific expression of oxytocin and vasopressin genes: an experimental odyssey.

Authors:  H Gainer
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

4.  Vasopressin RNA in the neural lobe of the pituitary: dramatic accumulation in response to salt loading.

Authors:  D Murphy; A Levy; S Lightman; D Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Somatic nonhomologous crossing-over between neuropeptide genes in rat hypothalamic neurons.

Authors:  E Mohr; A Peters; J F Morris; D Richter
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

6.  Regulation of vasopressin gene expression: changes in the level, but not the size, of vasopressin mRNA following endocrine manipulations.

Authors:  D A Carter; K Pardy; D Murphy
Journal:  Cell Mol Neurobiol       Date:  1993-02       Impact factor: 5.046

Review 7.  Cyclic Peptides that Govern Signal Transduction Pathways: From Prokaryotes to Multi-Cellular Organisms.

Authors:  Ryan W Mull; Anthony Harrington; Lucia A Sanchez; Yftah Tal-Gan
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

8.  Arginine vasopressin gene regulation in the homozygous Brattleboro rat.

Authors:  J K Kim; F Soubrier; J B Michel; L Bankir; P Corvol; R W Schrier
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

9.  Decrease in hypothalamic vasopressin mRNA poly(A) tail length following physiological stimulation.

Authors:  K F Chooi; D A Carter; D Murphy
Journal:  Cell Mol Neurobiol       Date:  1992-12       Impact factor: 5.046

Review 10.  Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system.

Authors:  Fabio Rotondo; Henriett Butz; Luis V Syro; George M Yousef; Antonio Di Ieva; Lina M Restrepo; Andres Quintanar-Stephano; Istvan Berczi; Kalman Kovacs
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.